Sanofi’s president of global oepraitons Hanspeter Spek is to retire.
His will step down in mid-2013 following 18 years service at the company he joined in 1985 as marketing director at Sanofi Pharma GmbH Germany.
Spek rose through the ranks , eventually being appointed to this current position in November, 2009.
“During his many years with Sanofi, Hanspeter has made an exceptional contribution to the success of the group and has helped bring Sanofi to the forefront of the industry,” said the company’s CEO Christopher Viehbacher.
“His early recognition of growing opportunities in the emerging markets has contributed to the building of Sanofi’s leading position there.”
During his time at Sanofi, he has helped with the success of several significant products, including bloodthinner Plavix, insulin Lantus and cancer drug Taxotere.
A succession plan is to be announced said Sanofi.